Bullet Biotechnology Inc - Company Review
Bullet Biotechnology Inc - Company ReviewSummary
Bullet Biotechnology Inc (Bullet Biotechnology) focuses on the development of immunotherapies for the treatment of cancer. The company’s lead product, BB-006 is under development which is being developed to treat solid tumors. Bullet Biotechnology’s primarily interest in is immuno-oncology applications that include multi-specific antibodies and active immunotherapies. The company utilizes its proprietary platform, Bullet Capsid Platform for the development of drugs. It also developed purification and release testing assays to secure the quality of product. The company works in partnership with academic and pharma organizations for the further development of immunotherapy products. Bullet Biotechnology is headquartered in Redwood City, California, the US.
This comprehensive company report of Bullet Biotechnology Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.